Concepedia

Priska Auf der Maur

PA

Statistics

Publications

4

Citations

185

H-Index

4

Active since

2021

Affiliations

University Hospital of Basel(Current)

University of Basel

SIB Swiss Institute of Bioinformatics

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Priska Auf der Maur is an author at University Hospital of Basel specializing in oncology, cancer cell signaling, and molecular oncology.

Publications per year

2021–2023

4

Publications

4

Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy

Marcel P. Trefny, Nicole Kirchhammer, Priska Auf der Maur et al. · Nature Communications · 2023 · 93 citations · Full text

Life Sciences, Immunology, Oncology +17

The NFIB‐ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells

Federica Zilli, Pedro Marques Ramos, Priska Auf der Maur et al. · EMBO Molecular Medicine · 2021 · 65 citations · Full text

Medicine, Cancer Biology, Oncology +16

N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer

Priska Auf der Maur, Marcel P. Trefny, Zora Baumann et al. · Cell Reports Medicine · 2023 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +17

A high-throughput drug screen reveals means to differentiate triple-negative breast cancer

Milica Vulin, Charly Jehanno, Atul Sethi et al. · Oncogene · 2022 · 13 citations · Full text

Medicine, Oncology, Pharmacology +14

1–4 of 4